Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms [Phase 1]
Phase 1 clinical trial update announcing JNJ-89853413 for relapsed or refractory acute myeloid leukemia and myelodysplastic neoplasms, curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies [Phase 1]
A Phase 1 study is evaluating ICP-248 in combination with azacitidine for myeloid malignancies, including acute myeloid leukemia and myelody…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) [Phase 2]
This is a Phase 2 clinical trial update for BLEX 404 Oral Liquid in patients with myelodysplastic syndromes and chronic myelomonocytic leuke…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation [NA]
This entry notes a clinical trial exploring an eHealth mindfulness-based music therapy intervention for patients undergoing stem cell transp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 study of CTX-712 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 trial comparing three treatment options for adults with low-risk myelodysplastic syndromes and anemia; status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial is evaluating dapagliflozin for treating anemia in patients with lower-risk myelodysplastic syndromes, currently no…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) [Phase 2]
A Phase 2 clinical trial evaluating the use of statins in patients with clonal cytopenia of undetermined significance (CCUS) and myelodyspla…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation [Phase 1]
This is a Phase 1 trial update announcing ongoing recruitment for a study evaluating TSC-100 and TSC-101 in patients with acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft [Phase 1]
A Stanford-sponsored Phase 1 trial is evaluating reduced-intensity, allogeneic hematopoietic cell transplantation with a T-cell–depleted gra…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating unrelated umbilical cord blood transplantation using CordIn ex vivo expanded cells to accelerate engraft…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy [NA]
This ClinicalTrials.gov entry describes a collaborative palliative and leukemia care model for patients with AML or myelodysplastic syndrome…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies [Phase 2]
Phase 2 clinical trial evaluating MT2021-08T, a T-cell receptor alpha/beta-depleted donor peripheral blood stem cell product, for hematologi…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) [Phase 2]
This update notes that the BMT-06 study of intensity-modulated total marrow irradiation (IM-TMI) is a Phase 2 trial currently recruiting for…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation [Phase 3]
Phase 3 trial comparing Ivosidenib monotherapy to Azacitidine monotherapy in IDH1-mutant, hypomethylating agent-naive myelodysplastic syndro…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) [Phase 2, Phase 3]
The AZTOUND study is evaluating ASTX030 (azacitidine and cedazuridine) alone or in combination with venetoclax in myeloid neoplasms includin…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation [Phase 1]
Phase 1 trial evaluating CIML NK cell infusion for relapse of myeloid disease after hematopoietic cell transplantation; the study is current…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of haploidentical hematopoietic cell transplantation for children with myelodysplasia and hematologic malignancie…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome [Phase 1]
A Phase 1 trial is evaluating iadademstat with a hypomethylating agent in patients with myelodysplastic syndromes. The study is currently re…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Telehealth Advance Care Planning Intervention [NA]
An ongoing clinical trial at the University of Rochester is evaluating a telehealth advance care planning intervention for myeloid malignanc…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
An ongoing National Cancer Institute study is evaluating molecular and clinical features of myelodysplastic syndromes in pediatric and adult…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Inqovi Maintenance Therapy in Myeloid Neoplasms [Phase 1]
Phase 1 trial update on Inqovi as maintenance therapy for myeloid neoplasms, including myelodysplastic syndromes and chronic myelomonocytic …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia [EARLY_Phase 1]
This early-phase trial update describes a study evaluating momelotinib in combination with a hypomethylating agent for Chronic Myelomonocyti…